From Wikitia
Jump to navigation Jump to search
Technology company
  • Biotechnology
  • Pharmaceuticals
  • Drug discovery
Number of employees

Arctoris Ltd is a technology company founded and headquartered in Oxford (UK) with its Asia-Pacific operations based in Singapore. Arctoris developed and operates a fully automated drug discovery platform, generating data from cell-based, molecular biology, biochemical, and biophysical assays conducted by robotics. Partnering researchers in biotechnology companies[1][2], pharmaceutical corporations and academic centres can design their assays and experiments online, and have them remotely executed in Arctoris’ robotic lab facility.[3] The team members’ backgrounds include biotechnology and pharmaceuticals, robotics and software engineering, medicine, as well as corporate strategy and marketing.


The drug discovery platform developed by Arctoris is based on a combination of laboratory robotics, digital assay data capture, and automated data analytics, generating significantly more data points per assay than manual laboratory operations.[4] This has been seen as a unique advantage for scenarios where access to large amounts of structured and accurate data is paramount, such as AI-driven drug discovery programs.

The company's automated platform provides remote on-demand access to assays and experiments in cellular biology, molecular biology, biochemistry, and biophysics.[5] Core components of the proprietary technologies developed by Arctoris are protected by granted and pending patents.[6]


Arctoris was founded in Oxford (UK) in 2016 by medical doctor and cancer researcher Martin-Immanuel Bittner and chemical biologist Thomas A. Fleming. Arctoris raised $10m via R&D grants and its pre-Seed and Seed round, funding the establishment of its automated laboratory facility, and its team as well as geographic expansion.[7] Operating from both Oxford and Singapore, Arctoris has established partnerships with biotech and pharma companies on three continents.[8][9][10] As of 2021, the company’s board of directors includes Martin-Immanuel Bittner (Co-Founder & CEO), Thomas A. Fleming (Co-Founder & COO), Vishal Gulati (Chairman), and John Mattick (Director). Other notable advisors and investors include Patrick Pichette, Charles R. Conn, Alexander Straub (entrepreneur), and John Wylie (businessman).

Honors and Awards

In 2020, Arctoris was awarded the Singapore Business Review International Business Award for the Innovator of the Year in Biotechnology.[11] The same year, Arctoris was highlighted as one of the top 10 biotech companies in Oxford.[12] In 2021, Arctoris was listed among 21 companies to watch in 2021 by the same outlet.[13]

The company’s Co-founder and CEO Martin-Immanuel Bittner received the highly prestigious Rhodes scholarship and was elected a member of the Young Academy of the German National Academy of Sciences Leopoldina in 2018.[14] Co-Founder & COO Thomas A. Fleming was made a Fellow of the 1851 Research Fellowship and named an SME Leader by the Royal Academy of Engineering.


External links

Add External links

This article "Arctoris" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.